Rankings
▼
Calendar
SNDX Q1 2016 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$305,000
Gross Profit
$305,000
100.0% margin
Operating Income
-$9M
-2869.8% margin
Net Income
-$10M
-3386.9% margin
EPS (Diluted)
$-2.27
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$136M
Total Liabilities
$22M
Stockholders' Equity
$114M
Cash & Equivalents
$23M
← FY 2016
All Quarters
Q2 2016 →
